Lantronix selects ADI's iCoupler technology to enable new wireless communication devices

NewsGuard 100/100 Score

Analog Devices, Inc. (ADI) today announced that Lantronix, Inc. has selected ADI's iCoupler® digital isolator technology to enable its new family of wireless communication network servers. The EDS-MD family of multiport medical device servers represents the latest in healthcare communications by providing remotely controlled system-level management of multiple medical devices in a compact, secure and lightweight plastic enclosure.

"Lantronix helps physicians, nurses, diagnosticians and hospital administrators develop more effective ways to manage patient care, whether through remote monitoring or data collection," said Daryl Miller, Vice President of Engineering for Lantronix. "Because of the healthcare industry's rigorous safety and reliability standards, we adopted ADI's iCoupler digital isolator technology to help deliver vital data faster, more securely and more efficiently to healthcare professionals so they can make better informed decisions about their patients' care."

According to an ABI Research study, revenue from sales of Wi-Fi-enabled healthcare products worldwide will total close to $5 billion in 2014. This represents an increase of nearly 70 percent over today's figure. With $20 billion allocated in the US stimulus bill for the digitizing of medical records, and an emphasis on a comprehensive reform of the healthcare industry at large, attention is focused as never before on the opportunities for wireless communications in healthcare.

Source: Analog Devices, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy